Karo Pharma's rights issue fully subscribed
HUDDINGE, Sweden, April 19, 2022 /PRNewswire/ -- Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa
Stay updated with breaking news from Jon Johnsson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HUDDINGE, Sweden, April 19, 2022 /PRNewswire/ -- Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa
Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, New Zealand, South Africa, Switzerland, Singapore, the United States or any other jurisdiction in which the distribution or release would be unlawful or require further registration measures.
HUDDINGE, Sweden, March 23, 2022 /PRNewswire/ -- The prospectus relating to the rights issue in Karo Pharma Aktiebolag ("Karo Pharma") of approximately SEK 2.5 billion (the "Rights Issue") has
HUDDINGE, Sweden, March 10, 2022 /PRNewswire/ -- Karo Pharma Aktiebolag (publ) (the "Company" or "Karo Pharma") announced in a press release on 9 March 2022 that Karo Pharma's Board of Directors
HUDDINGE, Sweden, Feb. 25, 2022 /PRNewswire/ -- Q4, October - December Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period. The